Trial doubles survival
FDA approves new pancreatic cancer drug
The FDA approves Revolution Medicines’ Rasonque for metastatic pancreatic cancer after a trial showed the drug doubled survival for patients.
The FDA approves Revolution Medicines’ Rasonque for metastatic pancreatic cancer after a trial showed the drug doubled survival for patients.

Researchers at the Weizmann Institute of Science have demonstrated how an emerging magnetic resonance imaging (MRI) approach could make pancreatic tumors 'light up' in MRI scans.

Team of scientists led by researchers from Hebrew University discover way to prevent pancreatic cancers from metastasizing.

Novel treatment reduces debilitating pain symptoms in 53 percent of patients.

A new mRNA vaccine is being studied as a potential cure for pancreatic cancer.

Israeli doctors develop new method to relieve pancreatic cancer pain by delivering radiation to nerve in solar plexus.
